Búsqueda Imágenes Maps Play YouTube Noticias Gmail Drive Más »
Iniciar sesión
Usuarios de lectores de pantalla: deben hacer clic en este enlace para utilizar el modo de accesibilidad. Este modo tiene las mismas funciones esenciales pero funciona mejor con el lector.

Patentes

  1. Búsqueda avanzada de patentes
Número de publicaciónWO1997012687 A1
Tipo de publicaciónSolicitud
Número de solicitudPCT/EP1996/004351
Fecha de publicación10 Abr 1997
Fecha de presentación4 Oct 1996
Fecha de prioridad4 Oct 1995
También publicado comoCA2232151A1, CA2232151C, CA2473681A1, CA2473681C, CA2551891A1, CA2551891C, CA2551999A1, CA2551999C, CN1091660C, CN1198689A, DE19536902A1, DE69629708D1, DE69629708T2, DE69636875D1, DE69636875T2, EP0853501A1, EP0853501B1, EP1214985A2, EP1214985A3, EP1214985B1, US5964416, US6402055, US6497373, US6726124, US6918547, US7104470, US20020130195, US20030080210, US20040178227, US20050252990, US20060285987
Número de publicaciónPCT/1996/4351, PCT/EP/1996/004351, PCT/EP/1996/04351, PCT/EP/96/004351, PCT/EP/96/04351, PCT/EP1996/004351, PCT/EP1996/04351, PCT/EP1996004351, PCT/EP199604351, PCT/EP96/004351, PCT/EP96/04351, PCT/EP96004351, PCT/EP9604351, WO 1997/012687 A1, WO 1997012687 A1, WO 1997012687A1, WO 9712687 A1, WO 9712687A1, WO-A1-1997012687, WO-A1-9712687, WO1997/012687A1, WO1997012687 A1, WO1997012687A1, WO9712687 A1, WO9712687A1
InventoresJoachim Jaeger, Pasquale Cirillo, Joachim Eicher, Johannes Geser, Bernhard Freund, Bernd Zierenberg
SolicitanteBoehringer Ingelheim International Gmbh
Exportar citaBiBTeX, EndNote, RefMan
Enlaces externos:  Patentscope, Espacenet
Device of miniaturised construction for producing high pressure in a fluid to be atomised
WO 1997012687 A1
Descripción  disponible en inglés
Reclamaciones  disponible en inglés
Citas de patentes
Patente citada Fecha de presentación Fecha de publicación Solicitante Título
FR2699390A1 * Título no disponible
GB2243880A * Título no disponible
US4260082 *18 Nov 19777 Abr 1981The Afa CorporationManually operated liquid dispensing device
US4623337 *8 Mar 198418 Nov 1986Alpha Group, Inc.Liquid dispensing apparatus
Citada por
Patente citante Fecha de presentación Fecha de publicación Solicitante Título
WO1999043571A126 Feb 19992 Sep 1999Boehringer Ingelheim International GmbhBehälter für eine medizinische flüssigkeit
WO2000023037A19 Oct 199927 Abr 2000Boehringer Ingelheim Pharma KgZweikammer-kartusche für vernebler
WO2000027543A18 Nov 199918 May 2000Boehringer Ingelheim International GmbhDruckausgleichsvorrichtung für einen doppelbehälter
WO2000049988A216 Feb 200031 Ago 2000Boehringer Ingelheim International GmbhKartusche für eine flüssigkeit
WO2003002045A126 Jun 20029 Ene 2003Boehringer Ingelheim Pharma Gmbh & Co. KgVernebler zur aufbringung von flüssigkeiten auf die augenhornhaut
WO2003020436A1 *16 Ago 200213 Mar 2003Boehringer Ingelheim International GmbhSperrspannwerk für einen miniaturisierten hochdruckzerstäuber
WO2003084539A2 *8 Abr 200316 Oct 2003Boehringer Ingelheim Pharma Gmbh & Co. KgNew pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
WO2003084539A3 *8 Abr 20032 Sep 2004Boehringer Ingelheim PharmaNew pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
WO2003097139A1 *23 Abr 200327 Nov 2003Boehringer Ingelheim International GmbhSystem umfassend eine düse und ein halterungssystem
WO2004022244A1 *26 Ago 200318 Mar 2004Boehringer Ingelheim Pharma Gmbh & Co. KgApparat zum ausbringen von flüssigkeiten, hierzu geeignete behälterpatrone, und system aus dem apparat zum ausbringen von flüssigkeiten und der behälterpatrone
WO2004024340A1 *23 Ago 200325 Mar 2004Boehringer Ingelheim International GmbhBlockiervorrichtung für ein sperrspannwerk mit federbetätigtem abtrieb
WO2004034009A130 Ago 200322 Abr 2004Boehringer Ingelheim Pharma Gmbh & Co.KgVerfahren zum messen der dichtigkeit von folienbehaeltnissen
WO2004089551A29 Ene 200421 Oct 2004Boehringer Ingelheim International GmbhDüsensystem für eine ausbringungsvorrichtung für flüssigkeiten bestehend aus düse und düsenhalter und/oder überwurfmutter
WO2005030213A122 Sep 20047 Abr 2005Boehringer Ingelheim Pharmaceuticals, Inc.1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo
WO2005065836A128 Dic 200421 Jul 2005Boehringer Ingelheim International GmbhVorrichtung zum haltern eines fluidischen bauteils
WO2005079895A124 Feb 20051 Sep 2005Boehringer Ingelheim International GmbhZerstäuber
WO2005079997A124 Feb 20051 Sep 2005Boehringer Ingelheim International GmbhZerstäuber
WO2005080001A124 Feb 20051 Sep 2005Boehringer Ingelheim International GmbhZerstäuber mit einer überwachungseinrichtung zur zählung von betätigungen des zerstäubers
WO2005080002A124 Feb 20051 Sep 2005Boehringer Ingelheim International GmbhZerstäuber mit kodiermitteln
WO2005102349A118 Abr 20053 Nov 2005Boehringer Ingelheim International GmbhArzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen
WO2005107837A1 *3 May 200517 Nov 2005Boehringer Ingelheim International GmbhZerstäuber zum ausbringen von flüssigkeiten für medizinische zwecke
WO2006125577A222 May 200630 Nov 2006Boehringer Ingelheim International GmbhNebuliser
WO2006136426A123 Jun 200628 Dic 2006Boehringer Ingelheim International GmbhNebuliser and container
WO2007003554A128 Jun 200611 Ene 2007Boehringer Ingelheim International GmbhNeue arzneimittelkombinationen zur behandlung von atemwegserkrankungen enthaltend langwirksame beta-2-agonisten und wenigstens einen weiteren wirkstoff
WO2007022898A214 Ago 20061 Mar 2007Boehringer Ingelheim International GmbhAtomiser comprising a counter and an end of operation lock
WO2007030162A218 May 200615 Mar 2007Nektar TherapeuticsValves, devices, and methods for endobronchial therapy
WO2007042467A16 Oct 200619 Abr 2007Boehringer Ingelheim International GmbhNeue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
WO2008014199A223 Jul 200731 Ene 2008Boehringer Ingelheim International GmbhSulfonyl compounds which modulate the cb2 receptor
WO2008017637A13 Ago 200714 Feb 2008Boehringer Ingelheim International GmbhArzneimittelkombinationen zur behandlung von atemwegserkrankungen
WO2008039645A113 Sep 20073 Abr 2008Boehringer Ingelheim International GmbhCompounds which modulate the cb2 receptor
WO2008046407A218 Oct 200724 Abr 2008Thomas BayerlVerwendung von deuteriumdioxid zur behandlung von hyperproliferativen erkrankungen der haut
WO2008107125A129 Feb 200812 Sep 2008Almirall, S.A.New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
WO2009003463A23 Jul 20088 Ene 2009D2O Bioscience Group Ltd.Verwendung von deuteriumoxid zur behandlung von virus-basierten erkrankungen der haut
WO2009047173A2 *30 Sep 200816 Abr 2009Boehringer Ingelheim International GmbhZerstäuber
WO2009047173A3 *30 Sep 200820 Ago 2009Boehringer Ingelheim IntZerstäuber
WO2010036630A222 Sep 20091 Abr 2010Boehringer Ingelheim International GmbhCompounds which selectively modulate the cb2 receptor
WO2010036631A222 Sep 20091 Abr 2010Boehringer Ingelheim International GmbhCompounds which selectively modulate the cb2 receptor
WO2010072354A115 Dic 20091 Jul 2010Almirall, S.A.MESYLATE SALT OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO }-1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR
WO2010079420A16 Ene 201015 Jul 2010D2 Bioscience Group Ltd.Verwendung von deuteriumoxid zur behandlung virus-basierter erkrankungen des respirationstraktes
WO2010080357A114 Dic 200915 Jul 2010Boehringer Ingelheim International GmbhSerotonin 5-ht2b receptor inhibitors
WO2010089391A18 Feb 201012 Ago 2010Boehringer Ingelheim International GmbhNew pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
WO2010094483A118 Feb 201026 Ago 2010Almirall, S.A.5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino} -1-hydroxyethyl) -8-hydroxyquinolin-2 (ih)-one for the treatment of lung function
WO2010094484A118 Feb 201026 Ago 2010Almirall, S.A.5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino}-l-hydroxyethyl) -8-hydroxyquin olin-2 (1h)-one and its use in the treatment of pulmonary diseases
WO2010097172A116 Feb 20102 Sep 2010Almirall, S.A.New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
WO2010112358A222 Mar 20107 Oct 2010Boehringer Ingelheim International GmbhVerfahren zur beschichtung einer oberfläche eines bauteils
WO2010147792A28 Jun 201023 Dic 2010Boehringer Ingelheim International GmbhCompounds which selectively modulate the cb2 receptor
WO2011005645A11 Jul 201013 Ene 2011Boehringer Ingelheim International GmbhPolymorph of [4,6-bis(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)pyrimidin-5-yl]
WO2011037795A115 Sep 201031 Mar 2011Boehringer Ingelheim International GmbhCompounds which selectively modulate the cb2 receptor
WO2011057757A19 Nov 201019 May 2011Almirall, S.A.New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one derivatives
WO2011066147A217 Nov 20103 Jun 2011Boehringer Ingelheim International GmbhNovel salt forms of pyrimidin-5-yl acetic acid derivative
WO2011066176A119 Nov 20103 Jun 2011Boehringer Ingelheim International GmbhProcess for preparing a polymorph of the choline salt of a pyrimidin-5-yl acetic acid derivative
WO2011088015A111 Ene 201121 Jul 2011Boehringer Ingelheim International GmbhCompounds which modulate the cb2 receptor
WO2011109324A11 Mar 20119 Sep 2011Boehringer Ingelheim International GmbhTetrazole compounds which selectively modulate the cb2 receptor
WO2011141180A113 May 201117 Nov 2011Almirall, S.A.NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
WO2011154295A21 Jun 201115 Dic 2011Boehringer Ingelheim International GmbhMedizinisches gerät mit zählwerk mit voreingestelltem zählbereich gerät mit zählwerksvariation
WO2012007315A15 Jul 201119 Ene 2012Boehringer Ingelheim International GmbhFiltersystem für den einsatz in medizinischen geräten
WO2012012307A118 Jul 201126 Ene 2012Boehringer Ingelheim International GmbhSulfonyl compounds which modulate the cb2 rece
WO2012027693A226 Ago 20111 Mar 2012Neonc Technologies Inc.Pharmaceutical compositions comprising poh derivatives
WO2012041476A126 Sep 20115 Abr 2012Almirall, S.A.Pyridine and isoquinoline derivatives as syk- and jak-kinase inhibitors
WO2012064631A17 Nov 201118 May 2012Boehringer Ingelheim International GmbhPyridyl ureas as mineralocorticoid receptor antagonists
WO2012069175A121 Nov 201131 May 2012Almirall, S.A.New pyrazole derivatives having crth2 antagonistic behaviour
WO2012069202A124 Nov 201131 May 2012Almirall,S.A.Imidazo [1,2-b] pyridazine and imidazo [4,5-b] pyridine derivatives as jak inhibitors
WO2012130757A123 Mar 20124 Oct 2012Boehringer Ingelheim International GmbhMedizinisches gerät mit behälter
WO2012146667A126 Abr 20121 Nov 2012Almirall, S.A.Imidazopyridine derivatives as pi3k inhibitors
WO2012160030A121 May 201229 Nov 2012Almirall, S.A.Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
WO2013010880A111 Jul 201224 Ene 2013Almirall, S.A.New crth2 antagonists
WO2013010881A111 Jul 201224 Ene 2013Almirall, S.A.NEW CRTh2 ANTAGONISTS
WO2013017461A123 Jul 20127 Feb 2013Almirall, S.A.Pyridin-2(1h)-one derivatives as jak inhibitors
WO2013068552A19 Nov 201216 May 2013Almirall, S.A.NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
WO2013068554A19 Nov 201216 May 2013Almirall, S.A.New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
WO2013139712A115 Mar 201326 Sep 2013Almirall, S.A.NOVEL POLYMORPHIC CRYSTAL FORMS OF 5-(2-{[6-(2,2-DIFLUORO-2-PHENYLETHOXY)HEXYL]AMINO}-1-(R)-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE, HEMINAPADISYLATE AS AGONIST OF THE β2 ADRENERGIC RECEPTOR.
WO2013152861A112 Abr 201317 Oct 2013Boehringer Ingelheim International GmbhNebuliser with coding means
WO2013152894A15 Mar 201317 Oct 2013Boehringer Ingelheim International GmbhZerstäuber mit kodiermitteln
WO2013153028A18 Abr 201317 Oct 2013Boehringer Ingelheim Microparts GmbhVerfahren zur herstellung von grabenartigen vertiefungen in der oberfläche eines wafers
WO2014060431A115 Oct 201324 Abr 2014Almirall, S.A.Pyrrolotriazinone derivatives as pi3k inhibitors
WO2014095920A117 Dic 201326 Jun 2014Almirall, S.A.New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity
WO2014124757A117 Feb 201421 Ago 2014Almirall, S.A.Pyrrolotriazine derivatives as pi3k inhibitors
WO2016170009A120 Abr 201627 Oct 2016Almirall, S.A.Amino-substituted heterocyclic derivatives as sodium channel inhibitors
WO2016202800A114 Jun 201622 Dic 2016Almirall, S.A.Pyrrolotriazinone derivatives as pi3k inhibitors
WO2017134127A12 Feb 201710 Ago 2017Boehringer Ingelheim Microparts GmbhMikrostrukturierte düse und deren herstellung
DE20221948U18 Jun 200224 Sep 2009Boehringer Ingelheim International GmbhVernebler mit Merkhilfe für das Therapieregiment
DE102004009434A1 *24 Feb 200415 Dic 2005Boehringer Ingelheim International GmbhZerstäuber
DE102004021789A1 *3 May 200427 Abr 2006Boehringer Ingelheim International GmbhZerstäuber zum Ausbringen von Flüssigkeiten für medizinische Zwecke
DE102005052898A1 *3 Nov 200510 May 2007Boehringer Ingelheim Pharma Gmbh & Co. KgVerfahren und Vorrichtung zum Dosieren von Arzneimitteln
DE102007020578A12 May 20076 Nov 2008Boehringer Ingelheim Pharma Gmbh & Co. KgWässrige Aerosolzubereitungen enthaltend therapeutisch wirksame Mikroorganismen oder Teile von Mikroorganismen und Verfahren zur Erzeugung entsprechender Aerosole
DE102007023012A115 May 200720 Nov 2008Boehringer Ingelheim Pharma Gmbh & Co. KgZerstäuber und Filter
DE102007031397A15 Jul 20078 Ene 2009D2O Bioscience Group Ltd.Verwendung von Deuteriumoxid zur Behandlung von Virus-basierten Erkrankungen der Haut
DE102009003992A17 Ene 20098 Jul 2010D2O Biosience Group Ltd., HamiltonVerwendung von Deuteriumoxid zur Behandlung Virus-basierter Erkrankungen des Respirationstraktes
DE202008015493U121 Nov 200812 Feb 2009Boehringer Ingelheim Pharma Gmbh & Co. KgFaltschachtel
EP1291013A29 Oct 199912 Mar 2003Boehringer Ingelheim Pharma KGLagerfähige Wirkstoffformulierungen
EP1312418A216 Oct 200221 May 2003Steag MicroParts GmbHZerstäuber für manuelle Betätigung
EP1338528A126 Feb 199927 Ago 2003BOEHRINGER INGELHEIM INTERNATIONAL GmbHBehälter für eine medizinische Flüssigkeit
EP1621197A29 Abr 20031 Feb 2006Boehringer Ingelheim Pharma GmbH & Co. KGArzneimittel enthaltend Steroide und ein Anticholinergikum
EP1658860A126 Jun 200324 May 2006Boehringer Ingelheim Pharma GmbH & Co. KGArzneimittelzusammensetzungen enthaltend Anticholinergika und EGFR-Kinase-Hemmer
EP1707205A226 Jun 20034 Oct 2006Boehringer Ingelheim Pharma GmbH & Co. KGPharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
EP1792660A19 Ene 20066 Jun 2007Boehringer Ingelheim Pharma GmbH & Co. KGDispensing device
EP1803469A217 Jul 20044 Jul 2007Boehringer Ingelheim Pharma GmbH & Co. KGMedicaments for inhalation comprising betamimetics and an anticholinergic
EP1891973A131 May 200527 Feb 2008Laboratorios Almirall, S.A.Combinations comprising antimuscarinic agents and PDE4 inhibitors
EP1891974A131 May 200527 Feb 2008Laboratorios Almirall, S.A.Combinations comprising antimuscarinic agents and PDE4 inhibitors
EP1905451A131 May 20052 Abr 2008Laboratorios Almirall, S.A.Combinations comprising antimuscarinic agents and corticosteroids
EP1949892A12 Abr 200330 Jul 2008Boehringer Ingelheim Pharma GmbH & Co. KGAerosolformulierung für die Inhalation enthaltend ein Tiotropiumsalz
EP2002843A231 May 200517 Dic 2008Laboratorios Almirall, S.A.Combinations comprising antimuscarinic agents and beta-adrenergic agonists
EP2002844A231 May 200517 Dic 2008Laboratorios Almirall, S.A.Combinations comprising antimuscarininc agents and beta-adrenergic agonists
EP2002845A231 May 200517 Dic 2008Laboratorios Almirall, S.A.Combinations comprising antimuscarinic agents and corticosteroids
EP2067779A129 Oct 200410 Jun 2009Boehringer Ingelheim International GmbHTiotropiumsalze, Verfahren zu deren Herstellung und Arzneimittelformulierungen diese enthaltend
EP2083007A129 Oct 200429 Jul 2009Boehringer Ingelheim International GmbhTiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen
EP2096105A128 Feb 20082 Sep 2009Laboratorios Almirall, S.A.Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
EP2108641A111 Abr 200814 Oct 2009Laboratorios Almirall, S.A.New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
EP2110132A120 Abr 200821 Oct 2009Firma D20 Biosience Group Ltd.Verwendung von Deuteriumoxid als Elastase-Inhibitor
EP2113503A128 Abr 20084 Nov 2009Laboratorios Almirall, S.A.New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
EP2116245A23 Ago 200511 Nov 2009Boehringer Ingelheim International GmbHEGFR kinase inhibitor combinations for treating respiratory and gastrointestinal disorders
EP2135632A120 Jun 200823 Dic 2009Boehringer Ingelheim International GmbhInhalator
EP2138188A131 May 200530 Dic 2009Almirall, S.A.Combinations comprising antimuscarinic agents and beta-adrenergic agonists
EP2221055A118 Feb 200925 Ago 2010Almirall, S.A.5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function
EP2221297A118 Feb 200925 Ago 2010Almirall, S.A.5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
EP2226323A127 Feb 20098 Sep 2010Almirall, S.A.New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
EP2236224A212 Mar 20106 Oct 2010Boehringer Ingelheim International GmbHUmformwerkzeug mit einem rotierbaren Grundkörper
EP2236227A212 Mar 20106 Oct 2010Boehringer Ingelheim International GmbHUmformwerkzeug mit einem rotierbaren Grundkörper
EP2246345A113 Feb 20043 Nov 2010Theravance IncBiphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
EP2263998A117 May 200622 Dic 2010Almirall S.A.Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor
EP2292267A231 May 20059 Mar 2011Almirall S.A.Combinations comprising antimuscarinic agents and beta-adrenergic agonists
EP2314380A3 *29 Sep 201014 Dic 2011Ing. Erich Pfeiffer GmbHAustragvorrichtung
EP2319538A231 May 200511 May 2011Almirall S.A.Combinations combrising antimuscarinic agents and corticosteroids
EP2319844A129 Oct 200411 May 2011Boehringer Ingelheim International GmbHTiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen
EP2322176A111 Nov 200918 May 2011Almirall, S.A.New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
EP2322522A129 Oct 200418 May 2011Boehringer Ingelheim International GmbhNeue Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen
EP2336126A129 Oct 200422 Jun 2011Boehringer Ingelheim International GmbHTiotropiumsalze, Verfahren zu deren Herstellung und Arzneimittelformulierungen diese enthaltend
EP2336127A129 Oct 200422 Jun 2011Boehringer Ingelheim International GmbHTiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen
EP2380890A123 Abr 201026 Oct 2011Almirall, S.A.New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
EP2381237A123 Abr 201026 Oct 2011Boehringer Ingelheim microParts GmbHVerfahren zur Bestimmung der Arbeitsweise einer Dosiervorrichtung
EP2386555A113 May 201016 Nov 2011Almirall, S.A.New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
EP2394998A131 May 201014 Dic 2011Almirall, S.A.3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
EP2422786A118 Abr 200529 Feb 2012Boehringer Ingelheim Pharma GmbH & Co. KGNeue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EP2436453A114 Ago 20064 Abr 2012Boehringer Ingelheim International GmbhAtomiser comprising a counter and an end of operation lock
EP2441755A130 Sep 201018 Abr 2012Almirall, S.A.Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
EP2447694A128 Oct 20102 May 2012Boehringer Ingelheim Pharma GmbH & Co. KGPrüfleck zur Überprüfung von Leckagemesssystemen
EP2452676A13 Jul 200816 May 2012D2 Bioscience Group LtdHydrogel enthaltend Deuteriumoxid zur Behandlung von Herpesvirus-basierten Erkrankungen der Haut
EP2457900A125 Nov 201030 May 2012Almirall, S.A.New pyrazole derivatives having CRTh2 antagonistic behaviour
EP2463289A126 Nov 201013 Jun 2012Almirall, S.A.Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
EP2489663A116 Feb 201122 Ago 2012Almirall, S.A.Compounds as syk kinase inhibitors
EP2508189A220 Abr 200810 Oct 2012D2 Bioscience Group LtdVerwendung von Deuteriumoxid als Elastase-Inhibitor
EP2518070A129 Abr 201131 Oct 2012Almirall, S.A.Pyrrolotriazinone derivatives as PI3K inhibitors
EP2518071A129 Abr 201131 Oct 2012Almirall, S.A.Imidazopyridine derivatives as PI3K inhibitors
EP2526945A125 May 201128 Nov 2012Almirall, S.A.New CRTH2 Antagonists
EP2527344A125 May 201128 Nov 2012Almirall, S.A.Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
EP2548863A118 Jul 201123 Ene 2013Almirall, S.A.New CRTh2 antagonists.
EP2548876A118 Jul 201123 Ene 2013Almirall, S.A.New CRTh2 antagonists
EP2554544A11 Ago 20116 Feb 2013Almirall, S.A.Pyridin-2(1h)-one derivatives as jak inhibitors
EP2592077A111 Nov 201115 May 2013Almirall, S.A.New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
EP2592078A111 Nov 201115 May 2013Almirall, S.A.New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
EP2641900A120 Mar 201225 Sep 2013Almirall, S.A.Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
EP2662472A222 Mar 201013 Nov 2013Boehringer Ingelheim International GmbhVerfahren zur Beschichtung einer Oberfläche eines Bauteils
EP2676694A212 Jun 200825 Dic 2013Boehringer Ingelheim International GmbHInhaler
EP2716635A18 Jun 20109 Abr 2014Boehringer Ingelheim International GmbHCompounds which selectively modulate the CB2 receptor
EP2738172A128 Nov 20124 Jun 2014Almirall, S.A.New bicyclic compounds as crac channel modulators
EP2774622A131 May 200510 Sep 2014Almirall, S.A.Combinations comprising antimuscarinic agents and beta-adrenergic agonists
EP2774623A131 May 200510 Sep 2014Almirall S.A.Combinations comprising antimuscarinic agents and beta-adrenergic agonists
EP2848615A13 Jul 201318 Mar 2015Almirall, S.A.New pyrazole derivatives as CRAC channel modulators
EP2883543A126 Ago 201117 Jun 2015Neonc Technologies Inc.Pharmaceutical compositions comprising perillyl alcohol carbamates
EP2893947A110 Ene 201415 Jul 2015Boehringer Ingelheim International GmbhZerstäuber
EP2898883A126 Ago 201129 Jul 2015Neonc Technologies Inc.Pharmaceutical compositions comprising perillyl alcohol carbamates
EP3012254A113 Feb 200427 Abr 2016Theravance Respiratory Company, LLCBiphenyl derivative and its use for treating pulmonary disorders
EP3135386A124 Feb 20051 Mar 2017Boehringer Ingelheim International GmbHZerstäuber
EP3173080A126 Ago 201131 May 2017Neonc Technologies Inc.Pharmaceutical compositions comprising poh derivatives
EP3202709A14 Feb 20169 Ago 2017Boehringer Ingelheim microParts GmbHMikrostrukturierte düse und deren herstellung
US64537955 Dic 199624 Sep 2002Boehringer Ingelheim International GmbhLocking mechanism for a spring-actuated device
US69454723 Sep 200220 Sep 2005Boehringer Ingelheim International GmbhLocking-stressing mechanism for a miniaturised high pressuriser
US698849623 Feb 200024 Ene 2006Boehringer Ingelheim International GmbhCartridge for a liquid
US70900931 Abr 200415 Ago 2006Boehringer Ingelheim International GmbhPressure compensation device for a two-part container
US72847135 Nov 200423 Oct 2007Boehringer Ingelheim International GmbhSystem comprising a nozzle and a fixing means therefor
US739634127 Ago 20038 Jul 2008Boehringer Ingelheim International GmbhBlocking device for a locking stressing mechanism having a spring-actuated output drive device
US742314625 Oct 20069 Sep 2008Boehringer Ingelheim International GmbhProcess for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
US745355616 Ene 200718 Nov 2008Boehringer Ingelheim International GmbhProcess for determining the particle size distribution of an aerosol and apparatus for carrying out such a process
US747042217 Ago 200630 Dic 2008Boehringer Ingelheim Pharma Gmbh & Co. KgMethod for the production of propellant gas-free aerosols from aqueous medicament preparations
US74917194 Oct 200617 Feb 2009Boehringer Ingelheim International GmbhEnantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments
US753700624 Feb 200526 May 2009Boehringer Ingelheim International GmbhNebulizer
US761107229 Jun 20063 Nov 2009Boehringer Ingelheim International GmbhMethod and device for atomizing liquid
US761169415 Jun 20063 Nov 2009Boehringer Ingelheim Pharma Gmbh & Co. KgAerosol formulation for inhalation comprising an anticholinergic
US76117092 May 20053 Nov 2009Boehringer Ingelheim Pharma Gmbh And Co. Kg1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
US762126614 Ene 200424 Nov 2009Boehringer Ingelheim International GmbhNozzle-system for a dispenser for fluids consisting of a nozzle and a nozzle-holder and/or screw cap
US764538314 Oct 200512 Ene 2010Boehringer Ingelheim International GmbhMicrostructured filter
US766546124 Feb 200523 Feb 2010Boehringer Ingelheim International GmbhNebulizer
US768181118 Jun 200723 Mar 2010Boehringer Ingelheim International GmbhSystem comprising a nozzle and a fixing means therefor
US769905226 Ago 200320 Abr 2010Boehringer Ingelheim Pharma Gmbh & Co. KgApparatus for the dispensing of liquids, container cartridge suitable for this, and system comprising the apparatus for the dispensing of liquids, and the container cartridge
US770947421 Ago 20074 May 2010Boehringer Ingelheim International GmbhEnantiomerically pure beta agonists, manufacturing and use thereof
US77233062 May 200525 May 2010Boehringer Ingelheim Pharma Gmbh & Co. KgSpray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
US77265881 Jul 20051 Jun 2010Boehringer Ingelheim International GmbhLocking-tensioning mechanism for a miniaturised high pressuriser
US77279622 May 20051 Jun 2010Boehringer Ingelheim Pharma Gmbh & Co. KgPowder comprising new compositions of oligosaccharides and methods for their preparation
US780256823 Sep 200528 Sep 2010Boehringer Ingelheim International GmbhCartridge for a liquid
US78193423 May 200526 Oct 2010Boehringer Ingelheim International GmbhAtomizer for dispensing liquids for medical purposes
US782358424 Ago 20062 Nov 2010Boehringer Ingelheim International GmbhAtomizer
US78372357 Ene 200523 Nov 2010Boehringer Ingelheim International GmbhDevice for clamping a fluidic component
US784985124 Feb 200514 Dic 2010Boehringer Ingelheim International GmbhNebulizer
US786740513 Jul 200411 Ene 2011Boehringer Ingelheim Pharma Gmbh & Co. KgProcess for producing microfluidic arrangements from a plate-shaped composite structure
US792812313 Sep 200719 Abr 2011Boehringer Ingelheim International GmbhCompounds which modulate the CB2 receptor
US793571523 Jul 20073 May 2011Boehringer Ingelheim International GmbhCompounds which modulate the CB2 receptor
US796461517 May 200621 Jun 2011Almirall, S.A.Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor
US804404618 May 200525 Oct 2011Boehringer Ingelheim Pharma Gmbh & Co KgMedicaments for the treatment of chronic obstructive pulmonary disease
US804889922 Sep 20091 Nov 2011Boehringer Ingelheim International GmbhCompounds which selectively modulate the CB2 receptor
US808728624 Jul 20063 Ene 2012Boehringer Ingelheim International, GmbhMethod for checking the permeability rate of a closed container
US817856824 Jun 200915 May 2012Boehringer Ingelheim International GmbhSulfone compounds which modulate the CB2 receptor
US817867910 Nov 200815 May 2012Almirall, S.A.Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptors
US82368624 Feb 20107 Ago 2012University Of Southern CaliforniaTherapeutic compositions comprising monoterpenes
US824217726 Abr 201114 Ago 2012Almirall, S.A.Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor
US82833428 Feb 20089 Oct 2012Almirall S.A.Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptor
US82991031 Jun 201030 Oct 2012Boehringer Ingelheim International GmbhCompounds which selectively modulate the CB2 receptor
US829911130 Nov 201030 Oct 2012Boehringer Ingelheim International GmbhCompounds which modulate the CB2 receptor
US83297351 Mar 201111 Dic 2012Boehringer Ingelheim International GmbhTetrazole compounds which selectively modulate the CB2 receptor
US834987121 Sep 20118 Ene 2013Boehringer Ingelheim International GmbhTherapeutic uses of compounds which selectively modulate the CB2 receptor
US836203925 Ago 201129 Ene 2013Boehringer Ingelheim International GmbhTherapeutic uses of compounds which selectively modulate the CB2 receptor
US837287422 Sep 200912 Feb 2013Boehringer Ingelheim International GmbhCompounds which selectively modulate the CB2 receptor
US83836158 Jun 201026 Feb 2013Boehringer Ingelheim International GmbhAzetidine 2-carboxamide derivatives which modulate the CB2 receptor
US838365115 Sep 201026 Feb 2013Boehringer Ingelheim International GmbhCompounds which selectively modulate the CB2 receptor
US838761428 Sep 20105 Mar 2013Boehringer Ingelheim International GmbhAtomizer
US839479117 Feb 200912 Mar 2013Boehringer Ingelheim International GmbhCrystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug
US847972526 Jun 20069 Jul 2013Boehringer Ingelheim International GmbhNebuliser
US852490812 Mar 20103 Sep 2013Almirall, S.A.Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
US865691024 May 200625 Feb 2014Boehringer Ingelheim International GmbhNebulizer
US868498015 Jul 20111 Abr 2014Corinthian Ophthalmic, Inc.Drop generating device
US873334116 Abr 200727 May 2014Boehringer Ingelheim International GmbhAtomizer and method of atomizing fluid with a nozzle rinsing mechanism
US873393515 Jul 201127 May 2014Corinthian Ophthalmic, Inc.Method and system for performing remote treatment and monitoring
US88290348 Feb 20119 Sep 2014Boehringer Ingerlheim International GmbHCompounds which modulate the CB2 receptor
US884693618 Jul 201130 Sep 2014Boehringer Ingelheim International GmbhSulfonyl compounds which modulate the CB2 receptor
US886574415 May 201421 Oct 2014Boehringer Ingelheim International Gmbh(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
US89165453 Ago 201223 Dic 2014Neonc Technologies Inc.Pharmaceutical compositions comprising POH derivatives
US89977359 Nov 20107 Abr 2015Boehringer Ingelheim International GmbhNebulizer
US902796718 Dic 200912 May 2015Boehringer Ingelheim International GmbhDevice for clamping a fluidic component
US905610020 Jun 201416 Jun 2015Almirall, S.A.Quinuclidine derivatives and medicinal compositions containing the same
US908714515 Jul 201121 Jul 2015Eyenovia, Inc.Ophthalmic drug delivery
US910801115 Abr 201018 Ago 2015Boehringer Ingelheim International GmbhInhalation device
US91089182 Oct 201218 Ago 2015Almirall, S.A.Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one via a novel intermediate
US921126916 Dic 201115 Dic 2015Neonc Technologies Inc.Methods and devices for using isoperillyl alcohol
US923803122 Nov 201319 Ene 2016Boehringer Ingelheim International GmbhPropellant-free aerosol formulation for inhalation
US92542629 Nov 20129 Feb 2016Almirall, S.A.Dosage and formulation
US931545411 Ene 201119 Abr 2016Boehringer Ingelheim International GmbhCompounds which modulate the CB2 receptor
US933319514 May 201510 May 2016Almirall, S.A.Quinuclidine derivatives and medicinal compositions containing the same
US934675915 Mar 201324 May 2016Almirall, S.A.Polymorphic crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one, heminapadisytlate as agonist of the β2 adrenergic receptor
US947474716 Jun 201525 Oct 2016Boehringer Ingelheim Vetmedica GmbhMuscarinic antagonists and combinations thereof for the treatment of airway disease in horses
US949946126 Ago 201122 Nov 2016Neonc Technologies, Inc.Pharmaceutical compositions comprising POH derivatives
US953311213 Jun 20083 Ene 2017Boehringer Ingelheim International GmbhInhaler
US954548712 Abr 201317 Ene 2017Boehringer Ingelheim International GmbhDispenser with encoding means
US965037016 May 201416 May 2017Centrexion Therapeutics Corporation(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
US968215320 Mar 201520 Jun 2017Nektar TherapeuticsPolymer conjugates of therapeutic peptides
US968220215 Dic 201520 Jun 2017Boehringer Ingelheim International GmbhAdapter, inhalation device, and atomizer
US96874789 Abr 201627 Jun 2017Almirall, S.A.Quinuclidine derivatives and medicinal compositions containing the same
US96876173 Dic 201327 Jun 2017Boehringer Ingelheim International GmbhNebulizer
US972448223 Nov 20108 Ago 2017Boehringer Ingelheim International GmbhNebulizer
US973752023 May 201622 Ago 2017Almirall, S.A.Aclidinium for use in improving the quality of sleep in respiratory patients
US97443137 Ago 201429 Ago 2017Boehringer Ingelheim International GmbhNebulizer
US975775030 Mar 201212 Sep 2017Boehringer Ingelheim International GmbhMedicinal device with container
US20130302260 *28 Feb 201314 Nov 2013Boehringer Ingelheim International GmbhNovel propellant containing preparations for tiotropium
USRE464179 Feb 201630 May 2017Almirall, S.A.Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
Clasificaciones
Clasificación internacionalF16K, B05B11/06, B05B11/00, B05B9/043, A47K5/12, F04B9/14, B65D83/76, A61M15/00, A61M11/00, F04B53/12, F04B53/10
Clasificación cooperativaA61M15/0071, A61M15/0081, Y10T137/7909, Y10T137/7913, Y10T137/7916, B05B11/308, B05B11/0043, A61M15/0068, B05B11/309, B05B11/3001, B05B11/3091, F04B53/125, B05B11/3067, A61M15/0065, A61M2205/7545, A61M15/00
Clasificación europeaA61M15/00D, B05B11/30H7B, B05B11/30C, B05B11/30P2, B05B11/30H9, F04B53/12R
Eventos legales
FechaCódigoEventoDescripción
10 Abr 1997AKDesignated states
Kind code of ref document: A1
Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM
10 Abr 1997ALDesignated countries for regional patents
Kind code of ref document: A1
Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG
12 Jun 1997DFPERequest for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
30 Jul 1997121Ep: the epo has been informed by wipo that ep was designated in this application
16 Mar 1998WWEWipo information: entry into national phase
Ref document number: 1996934565
Country of ref document: EP
16 Mar 1998ENPEntry into the national phase in:
Ref country code: CA
Ref document number: 2232151
Kind code of ref document: A
Format of ref document f/p: F
Ref document number: 2232151
Country of ref document: CA
24 Mar 1998WWEWipo information: entry into national phase
Ref document number: 320179
Country of ref document: NZ
25 Mar 1998WWEWipo information: entry into national phase
Ref document number: 1019980702174
Country of ref document: KR
1 Abr 1998ENPEntry into the national phase in:
Ref document number: 42698
Country of ref document: SK
Kind code of ref document: A
1 Abr 1998WWEWipo information: entry into national phase
Ref document number: 42698
Country of ref document: SK
3 Abr 1998WWEWipo information: entry into national phase
Ref document number: PV1998-1015
Country of ref document: CZ
3 Abr 1998ENPEntry into the national phase in:
Ref country code: JP
Ref document number: 1997 513985
Kind code of ref document: A
Format of ref document f/p: F
12 Jun 1998ENPEntry into the national phase in:
Ref document number: 80498
Country of ref document: SK
Kind code of ref document: A
12 Jun 1998WWEWipo information: entry into national phase
Ref document number: 80498
Country of ref document: SK
22 Jul 1998WWPWipo information: published in national office
Ref document number: 1996934565
Country of ref document: EP
6 Ago 1998REGReference to national code
Ref country code: DE
Ref legal event code: 8642
17 Feb 1999WWPWipo information: published in national office
Ref document number: PV1998-1015
Country of ref document: CZ
26 Jul 1999WWPWipo information: published in national office
Ref document number: 1019980702174
Country of ref document: KR
27 Ago 2003WWGWipo information: grant in national office
Ref document number: 1996934565
Country of ref document: EP
13 Feb 2004WWGWipo information: grant in national office
Ref document number: 1019980702174
Country of ref document: KR
18 May 2005WWGWipo information: grant in national office
Ref document number: PV1998-1015
Country of ref document: CZ